CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro

Leukemia and Lymphoma

Volumn 53, Issue 10, 2012, Pages 1988-1998

  Burgess, Melinda ^a   Cheung, Catherine ^a   Chambers, Lynne ^a   Ravindranath, Karunya ^a   Minhas, Gunjeet ^a   Knop, Louise ^a   Mollee, Peter ^a   McMillan, Nigel A J ^a,b   Gill, Devinder ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

CCL2; Chemokine; CLL; CXCL2; Microenvironment

Indexed keywords

ANTIBODY; CXCL2 CHEMOKINE; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1;

ACCESSORY CELL; ARTICLE; CANCER SURVIVAL; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; COCULTURE; HUMAN; HUMAN CELL; IMMUNOASSAY; LEUKEMIA CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CELL COMMUNICATION; CELL SURVIVAL; CHEMOKINE CCL2; CHEMOKINE CXCL2; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PRIMARY CELL CULTURE; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT;

EID: 84865763578     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.672735     Document Type: Article

References (40)

1. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. NEngl JMed 2005;352:804-815
2. Collins RJ, Verschuer LA, Harmon BV, et al. Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. Br JHaematol 1989;71:343-350.
3. O'Brien S, Kay NE. Maintenance therapy for B-chronic lymphocytic leukemia. Clin Adv Hematol Oncol 2011;9:22-31.
4. Munk Pedersen I, Reed J. Microenvironmental interactions and survival of CLLB-cells. Leuk Lymphoma 2004;45:2365-2372.
5. Hayden RE, Pratt G, Roberts C, et al. Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches. Leuk Lymphoma 2011 Sep 23. [Epub ahead of print]
6. Messmer BT, Messmer D, Allen SL, et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia Bcells. JClin Invest 2005;115:755-764.
7. van Gent R, Kater AP, Otto SA, et al. In vivo dynamics of stable chronic lymphocytic leukemia inversely correlate with somatic hypermutation levels and suggest no major leukemic turnover in bone marrow. Cancer Res 2008;68:10137-10144.
8. Schillaci R, Galeano A, Becu-Villalobos D, et al. Autocrine/paracrine involvement of insulin-like growth factor-Iand its receptor in chronic lymphocytic leukaemia. Br JHaematol 2005;130:58-66.
9. Dancescu M, Rubio-Trujillo M, Biron G, et al. Interleukin 4 protects chronic lymphocytic leukemic Bcells from death by apoptosis and upregulates Bcl-2 expression. JExp Med 1992;176:1319-1326.
10. Francia di Celle P, Mariani S, Riera L, et al. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood 1996;87:4382-4389.
11. Chaouchi N, Wallon C, Goujard C, et al. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia Bcells from in vitro apoptosis. Blood 1996;87:1022-1029.
12. Burger JA, Quiroga MP, Hartmann E, et al. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia Bcells in nurselike cell cocultures and after BCRstimulation. Blood 2009;113:3050-3058.
13. Ticchioni M, EssafiM, Jeandel PY, et al. Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a. Oncogene 2007;26: 7081-7091.
14. Pedersen IM, Kitada S, Leoni LM, et al. Protection of CLLBcells by a follicular dendritic cell line is dependent on induction of Mcl-1. Blood 2002;100:1795-1801.
15. Kay NE, Shanafelt TD, Strege AK, et al. Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an " angiogenic switch " Leuk Res 2007;31:899-906.
16. Panayiotidis P, Jones D, Ganeshaguru K, et al. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br JHaematol 1996;92: 97-103.
17. Burger JA, Tsukada N, Burger M, et al. Blood-derived nurse-like cells protect chronic lymphocytic leukemia Bcells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 2000;96: 2655-2663.
18. Gamberale R, Geffner J, Arrosagaray G, et al. Non-malignant leukocytes delay spontaneous B-CLLcell apoptosis. Leukemia 2001; 15:1860-1867.
19. Levesque MC, O'Loughlin CW, Weinberg JB. Use of serum-free media to minimize apoptosis of chronic lymphocytic leukemia cells during in vitro culture. Leukemia 2001;15:1305-1307.
20. Seiffert M, Schulz A, Ohl S, et al. Soluble CD14 is a novel monocytederived survival factor for chronic lymphocytic leukemia cells, which is induced by CLLcells in vitro and present at abnormally high levels in vivo. Blood 2010;116:4223-4230.
21. Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990-4997.
22. Kurtova AV, Balakrishnan K, Chen R, et al. Diverse marrow stromal cells protect CLLcells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood 2009;114:4441-4450.
23. Moreno A, Villar ML, Camara C, et al. Interleukin-6 dimers produced by endothelial cells inhibit apoptosis of B-chronic lymphocytic leukemia cells. Blood 2001;97:242-249.
24. Ben-Baruch A. The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev 2006;25:357-3571.
25. Vicari AP, Caux C. Chemokines in cancer. Cytokine Growth Factor Rev 2002;13:143-154.
26. Bomstein Y, Yuklea M, Radnay J, et al. The antiapoptotic effects of blood constituents in patients with chronic lymphocytic leukemia. Eur JHaematol 2003;70:290-295.
27. Raman D, Baugher PJ, Thu YM, et al. Role of chemokines in tumor growth. Cancer Lett 2007;256:137-165.
28. Diaz-Guerra E, Vernal R, del Prete MJ, et al. CCL2 inhibits the apoptosis program induced by growth factor deprivation, rescuing functional Tcells. JImmunol 2007;179:7352-7357.
29. Tarzami ST, Calderon TM, Deguzman A, et al. MCP-1/CCL2 protects cardiac myocytes from hypoxia-induced apoptosis by a G(alphai)-independent pathway. Biochem Biophys Res Commun 2005;335:1008-1016.
30. Pinto LA, Williams MS, Dolan MJ, et al. Beta-chemokines inhibit activation-induced death of lymphocytes from HIV-infected individuals. Eur JImmunol 2000;30:2048-2055.
31. Kobayashi M, Kabashima K, Nakamura M, et al. Downmodulatory effects of the antihistaminic drug bepotastine on cytokine/chemokine production and CD54 expression in human keratinocytes. Skin Pharmacol Physiol 2009;22:45-48.
32. Lai R, O'Brien S, Maushouri T, et al. Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia. Cancer 2002;95:1071-1075.
33. Biswas P, Delfanti F, Bernasconi S, et al. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 1998;91:258-265.
34. Ghia P, Strola G, Granziero L, et al. Chronic lymphocytic leukemia Bcells are endowed with the capacity to attract CD4+, CD40L+Tcells by producing CCL22. Eur JImmunol 2002;32:1403-1413.
35. Barretina J, Junca J, Llano A, et al. CXCR4 and SDF-1 expression in B-cell chronic lymphocytic leukemia and stage of the disease. Ann Hematol 2003;82:500-505.
36. Burger M, Hartmann T, Krome M, et al. Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia Bcells. Blood 2005;106:1824-1830.
37. Rojas R, Roman J, Torres A, et al. Inhibition of apoptotic cell death in B-CLLby interferon gamma correlates with clinical stage. Leukemia 1996;10:1782-1788.
38. Chunsong H, Yuling H, Li W, et al. CXCchemokine ligand 13 and CCchemokine ligand 19 cooperatively render resistance to apoptosis in Bcell lineage acute and chronic lymphocytic leukemia CD23+CD5+Bcells. JImmunol 2006;177:6713-6722.
39. Lagneaux L, Delforge A, Bron D, et al. Chronic lymphocytic leukemic Bcells but not normal Bcells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood 1998;91:2387-2396. Burkle A[40], Niedermeier M, Schmitt-GraffA, et al. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Blood 2007;110:3316-3325.
40. Zucchetto A, Benedetti D, Tripodo C, et al. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. Cancer Res 2009;69:4001-4009.